Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Anderson

Showing results (321-330 of 499) with videos related to

Pageof 50
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1991
Hypovolemic shock promotes neutrophil sequestration in lungs by a xanthine oxidase-related mechanismB O Anderson, E E Moore, F A Moore, et al.
Cancer|October 7, 2008
Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocationAlexandru Eniu, Robert W Carlson, Nagi S El Saghir, et al.
European Journal of Medicinal Chemistry|December 6, 2024
High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diureticsRiya J Master, Joy Karmakar, Peter M Haggie, et al.
Surgery|August 1, 1990
Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanismsB O Anderson, J M Brown, D D Bensard, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigenLisa Y Wu, Marc O Anderson, Yoko Toriyabe, et al.
The Lancet. Oncology|November 3, 2009
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Ross A Soo, Benjamin O Anderson, Byoung Chul Cho, et al.
Lancet (London, England)|November 6, 2016
Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countriesLynette Denny, Silvia de Sanjose, Miriam Mutebi, et al.
RSC Medicinal Chemistry|November 17, 2023
Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disordersTifany Chu, Joy Karmakar, Peter M Haggie, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
Substrate specificity of prostate-specific membrane antigenMarc O Anderson, Lisa Y Wu, Nicholas M Santiago, et al.
BMC Health Services Research|September 22, 2011
Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North AfricaJohn F P Bridges, Benjamin O Anderson, Antonio C Buzaid, et al.
Pageof 50

Showing results (321-330 of 499) with videos related to

Sort By:
Pageof 50
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 1, 1991
Hypovolemic shock promotes neutrophil sequestration in lungs by a xanthine oxidase-related mechanismB O Anderson, E E Moore, F A Moore, et al.
Cancer|October 7, 2008
Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocationAlexandru Eniu, Robert W Carlson, Nagi S El Saghir, et al.
European Journal of Medicinal Chemistry|December 6, 2024
High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diureticsRiya J Master, Joy Karmakar, Peter M Haggie, et al.
Surgery|August 1, 1990
Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanismsB O Anderson, J M Brown, D D Bensard, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigenLisa Y Wu, Marc O Anderson, Yoko Toriyabe, et al.
The Lancet. Oncology|November 3, 2009
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009Ross A Soo, Benjamin O Anderson, Byoung Chul Cho, et al.
Lancet (London, England)|November 6, 2016
Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countriesLynette Denny, Silvia de Sanjose, Miriam Mutebi, et al.
RSC Medicinal Chemistry|November 17, 2023
Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disordersTifany Chu, Joy Karmakar, Peter M Haggie, et al.
Bioorganic & Medicinal Chemistry|September 4, 2007
Substrate specificity of prostate-specific membrane antigenMarc O Anderson, Lisa Y Wu, Nicholas M Santiago, et al.
BMC Health Services Research|September 22, 2011
Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North AfricaJohn F P Bridges, Benjamin O Anderson, Antonio C Buzaid, et al.
Pageof 50